Interventions for Frailty in Older Adults with Cardiovascular Disease – A Comprehensive Review

The first author @NailaIjaz_MD is a humble, hardworking, and just outstanding.

jacc.org/doi/10.1016/j.…

Summary of this @JACCjournal state-of-the-art review is in 🧵below:

(1/17)
(2/17)

The aging of the United States population is one of four major areas that will change science, clinical medicine, and business in the coming 50 years

@anatlechner @NYUStern
(3/17)

1 in 4 Americans will be above 65 years of age by 2060…

Think about the implications of this on everyday life...

@DEF_gericard
(4/17) Older adults are disproportionally affected with cardiovascular disease, but they also live with geriatric syndromes.

Geriatric syndromes are age-related conditions that do not fall into one disease category!

@KAlexanderMD @SHummelMD @ParagGoyalMD @NRohant
(5/17) Geriatric Syndromes complicate and worsen cardiovascular disease management and outcomes and in turn cardiovascular disease worsens geriatric syndromes management and outcomes.

@christi36702158 @omsmanu
E.g. AMI can cause worsening in physical or cognitive dysfunction and also physical or cognitive dysfunction can lead to worse AMI outcomes compared to controls.
(6/17) Frailty is an important geriatric syndrome that has major implications on cardiovascular disease management.
(7/17) Let's be clear on domains of frailty.

There is:

(1) Physical frailty
(2) Cognitive frailty
(3) Psychosocial frailty
(4) Nutritional frailty

Important to distinguish what domain we are looking at

@FrailtyScience @JHGeriatrics @bbuta410
(8/17) Many definitions of frailty were proposed, but most cited is “clinical syndrome of increased vulnerability resulting from age-associated decline in reserve and function across multiple physiologic systems such that the ability to cope with everyday stress is compromised”
(9/17) Many instruments are used to measure frailty, but these are capturing different populations.

Please look at Table 2 extends into 3 pages!

Time to standardize our definition and measurement

Time to FARC @FrailtyMD @DrMauricioCohen
(10/17)

Frailty and cardiovascular disease have bidirectional associations.

Both have similar underlying cellular physiologic dysfunction.

For these reasons, frailty should also be studied as an outcome (not only as an exposure)...

That is why Rehab HF is a pillar.
(11/17) Work by my friends: Dr. Qian-Li Xue and @bbuta410 showed that frailty may be modifiable and the risk changes over time, but for advance forms of frailty risk may not be reversible. We need to catch early and intervene.

Ref: Analyses from the NHATS...
(12/17) So what do we do about frailty syndrome?

For physical frailty: structured, supervised, and tailored cardiac rehabilitation programs combined with cognitive and nutritional interventions are showing great promise…
(13/17) Several pharmacologic interventions are undergoing study targeting underlying pathophysiologic mechanisms of frailty summarized in Table 3.
(14/17) Nutritional intervention combined with resistance exercise may also have a role…

Early work from Frailty-AVR by @FrailtyMD (leading the field).
(15/17) There are cognitive and psychosocial interventions that will improve medication adherence and health literacy for older patients with cardiovascular disease.

@Jennifer_Rymer @TYWangMD
(16/17) Gaps in knowledge include whether there are interventions we can do to reduce risk of MACE particularly as it relates to cardiovascular interventions: #RadialFirst, percutaneous over surgical treatments, and other pharmacologic modification

@MichaelGNanna @Ajar_Kochar
(17/17) Finally, we need trials for the older adult populations to account for geriatric and age-related risks

@VijayKunadian @GreggWStone @DLBHATTMD @DEF_gericard
p.s. @NailaIjaz_MD's first publication as a first author is in @JACCJournals

Imagine what she can do if given the opportunity!

She will make a great cardiologist, friends.

@InovaHealth @IHVInews

• • •

Missing some Tweet in this thread? You can try to force a refresh
 

Keep Current with Abdulla A. Damluji, MD, PhD | 🏊🏻‍♂️🚴🏻‍♂️🏃🏻

Abdulla A. Damluji, MD, PhD | 🏊🏻‍♂️🚴🏻‍♂️🏃🏻 Profile picture

Stay in touch and get notified when new unrolls are available from this author!

Read all threads

This Thread may be Removed Anytime!

PDF

Twitter may remove this content at anytime! Save it as PDF for later use!

Try unrolling a thread yourself!

how to unroll video
  1. Follow @ThreadReaderApp to mention us!

  2. From a Twitter thread mention us with a keyword "unroll"
@threadreaderapp unroll

Practice here first or read more on our help page!

More from @DrDamluji

Jan 31
1/4
Few months after pci transfer for NSTEMI

Yes to ivus or no to ivus ?
2/4 perpendicular cranial view
3/4

Pre and post ivus
Read 4 tweets
Nov 15, 2021
Great session #AHA2021

Cardiovascular Quality and Outcomes: An International Collaboration

@UmeshKhotMD @emilycob
The push for cardiovascular interventions on the interventional level - beyond the U.S.

Mark Huffman of @NorthwesternU
Funding on the international level.

$50 million from @nih_nhlbi and $30 million from @AHAScience to improve the global cardiovascular care.

#AHA2021
Read 12 tweets
Nov 15, 2021
Re: ideas on #risk, #prediction, #data, and #life, which were inspired by a #random phone call during a break from classes @NYUStern:

Short thread below 👇🏻

@nntaleb
1 The information you have is not the information you want.
2 The information you want is not the information you need.
Read 6 tweets
Nov 5, 2021
SURTAVI

No differences in death ,stroke, MI, or HF between TAVR and Surgery during longer follow-up

#TCT2021
Hemodynamics

Total AR and PVL

KCCQ no difference after 1 year

NYHA class at one year 1
Summary for SURTAVI

Self expanding valve

#TCT2021
Read 26 tweets
Nov 5, 2021
Cardiac Arrest and Cardiogenic Shock

There is a societal paper on this in the works too!

Very important work!

@Babar_Basir @venumenon10

#TCT2021 @TCTMD
Methylprednisone - ? not helpful

Advanced reperfusion strategies - small trial

#TCT2021
SCAI Shock Classification

Milrinone vs Dobutamine - no difference

Gaps in pressers in CICU setting: pressers and antiplatelets

@seanvandiepen @JasonKatzMD

#TCT2021
Read 20 tweets
Nov 5, 2021
The use of LV venting to prevent LV thrombus!

#TCT2021
Cardiogenic shock data: excellent presentation by @thiele_holger @HenrytTimothy

#TCT2021
Outcomes in registries = @InovaHealth is up there :)

NCSI data.

@Babar_Basir @BillONeillMD
Read 6 tweets

Did Thread Reader help you today?

Support us! We are indie developers!


This site is made by just two indie developers on a laptop doing marketing, support and development! Read more about the story.

Become a Premium Member ($3/month or $30/year) and get exclusive features!

Become Premium

Don't want to be a Premium member but still want to support us?

Make a small donation by buying us coffee ($5) or help with server cost ($10)

Donate via Paypal

Or Donate anonymously using crypto!

Ethereum

0xfe58350B80634f60Fa6Dc149a72b4DFbc17D341E copy

Bitcoin

3ATGMxNzCUFzxpMCHL5sWSt4DVtS8UqXpi copy

Thank you for your support!

:(